SILVERARC CAPITAL MANAGEMENT, LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 41 filers reported holding LEAP THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SILVERARC CAPITAL MANAGEMENT, LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,806,000
-45.0%
1,032,163
+1.8%
0.75%
-43.9%
Q4 2021$3,284,000
+32.1%
1,013,664
+63.5%
1.33%
-5.3%
Q3 2021$2,486,000
+336.1%
620,000
+106.7%
1.40%
+351.8%
Q1 2021$570,000
-7.9%
300,000
+9.1%
0.31%
-13.6%
Q4 2020$619,000275,0000.36%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders